Project UPLIFT for Psychogenic Non-Epileptic Seizures
PNES
The Feasibility of Project UPLIFT for the Treatment of Psychogenic Non-Epileptic Seizures
1 other identifier
interventional
8
1 country
1
Brief Summary
Developed by researchers from the Centers for Disease Control and Prevention (CDC), Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a group telephone program designed to improve depression for people with epilepsy. Project UPLIFT uses evidence-based approaches of cognitive-behavioral therapy (CBT) and mindfulness-based cognitive therapy to help people manage and prevent symptoms of depression. For people with psychogenic non-epileptic seizures, there are few treatment options for depression that address the relationship between mood and seizures. There is evidence that mindfulness-based therapy and cognitive therapy are both effective for people with non-epileptic seizures, both in treating depression and reducing seizure frequency. In this study, Project UPLIFT will be offered to patients with psychogenic non-epileptic seizures. Project UPLIFT is facilitated by a trained clinician to groups of 4-8 patients over the telephone. The group will meet at a regular time, once a week, for 8 consecutive weeks. Participants will be assigned to one of two groups: an immediate-treatment or a waitlist control group which will begin Project UPLIFT 3 months after enrolling in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2017
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedStudy Start
First participant enrolled
July 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedSeptember 28, 2021
September 1, 2021
1.9 years
October 20, 2017
September 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
80% of participants who begin Session 1 of UPLIFT will complete 80% of the sessions.
To test the feasibility of giving Project UPLIFT to patients with PNES
6 months
Secondary Outcomes (4)
Change in depression (Patient Health Questionnaire-9) before and after intervention.
6 months
Change in seizure frequency as assessed by self-report seizure questionnaire.
6 months
Change in anxiety (Generalized Anxiety Disorder-7) before and after the intervention.
6 months
Change in symptoms of Post-Traumatic Stress Disorder (PTSD Checklist-Civilian Version, PCL-C) before and after the intervention.
6 months
Study Arms (2)
Immediate-Treatment
EXPERIMENTALThis group will receive Project UPLIFT immediately after completing surveys.
Waitlist Control
ACTIVE COMPARATORThis group will receive Project UPLIFT after waiting approximately 3 months to begin the intervention.
Interventions
A group, telephone-based intervention for depression that uses techniques from mindfulness-based therapy and cognitive therapy. The intervention consists of 8 sessions occurring at the same time and day every week.
Eligibility Criteria
You may qualify if:
- History of psychogenic non-epileptic seizures, confirmed by study investigator.
- Literate
- Reliable telephone access
You may not qualify if:
- Dual diagnosis of PNES with epilepsy.
- Presence of serious mental illness that will impair ability to participate.
- Presence of active suicidal ideation at baseline with intention to act.
- Severe mental disability or estimated intelligent quotient (IQ) less than 70.
- No reliable telephone access.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsay Schommer, APRN
Dartmouth-Hitchcock Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adv Prac Nrs, Neurology
Study Record Dates
First Submitted
October 20, 2017
First Posted
November 6, 2017
Study Start
July 23, 2018
Primary Completion
June 30, 2020
Study Completion
December 31, 2020
Last Updated
September 28, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) are not planned to be shared without outside researchers.